Clinical Trial Update: An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

An ascending multiple-dose study of the investigational drug VTP-38543 in adults with mild-to-moderate atopic dermatitis (Phase 1/2) has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• VTP-38543

Snippet

Sponsor: Vitae Pharmaceuticals, Inc. | Conditions: Dermatitis, Atopic | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-02-15